Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Decreases By 34.8%

Edap Tms S.A. (NASDAQ:EDAP) saw a large drop in short interest in the month of February. As of February 27th, there was short interest totaling 58,380 shares, a drop of 34.8% from the February 12th total of 89,522 shares. Based on an average daily volume of 51,440 shares, the days-to-cover ratio is presently 1.1 days. Currently, 0.2% of the shares of the company are sold short. Currently, 0.2% of the shares of the company are sold short. Based on an average daily volume of 51,440 shares, the days-to-cover ratio is presently 1.1 days.

Hedge Funds Weigh In On Edap Tms

A number of hedge funds have recently made changes to their positions in the business. Rock Springs Capital Management LP grew its position in shares of Edap Tms by 1.3% during the fourth quarter. Rock Springs Capital Management LP now owns 1,286,500 shares of the medical equipment provider’s stock worth $4,233,000 after purchasing an additional 16,500 shares in the last quarter. Kovack Advisors Inc. purchased a new position in Edap Tms in the 4th quarter worth approximately $53,000. Flax Pond Capital LLC bought a new position in Edap Tms in the 4th quarter worth approximately $2,623,000. Leonteq Securities AG purchased a new stake in Edap Tms during the 4th quarter valued at approximately $313,000. Finally, Financial Planning Navigators CORP purchased a new stake in Edap Tms during the 4th quarter valued at approximately $33,000. Institutional investors own 62.74% of the company’s stock.

Edap Tms Price Performance

Shares of EDAP stock traded down $0.11 on Friday, hitting $3.92. 8,020 shares of the stock traded hands, compared to its average volume of 76,119. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.41 and a quick ratio of 0.97. Edap Tms has a 52 week low of $1.21 and a 52 week high of $5.05. The firm has a 50 day simple moving average of $4.22 and a two-hundred day simple moving average of $3.05. The firm has a market cap of $146.57 million, a price-to-earnings ratio of -6.88 and a beta of -0.19.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on EDAP shares. Wall Street Zen raised Edap Tms to a “hold” rating in a report on Saturday, February 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a research report on Monday, December 29th. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $8.50.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.